Addressing Real-world Anticoagulant Management Issues in Stroke
NCT02478177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2020-02-26
Summary
The Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry is designed to provide important and timely insight into the management of acute stroke patients who are on novel oral anticoagulants in community practice.
Conditions
- Stroke
- Cerebrovascular Stroke
- Intracerebral Hemorrhage
Sponsors & Collaborators
-
Janssen, LP
collaborator INDUSTRY -
Genentech, Inc.
collaborator INDUSTRY - collaborator INDUSTRY
- collaborator OTHER
- lead OTHER
Principal Investigators
-
Ying Xian, MD, PhD · Duke UMC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Acute Ischemic Stroke Interventional Study
NCT03803007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study
NCT02784717 ·Status: COMPLETED
-
Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis
NCT03062319 ·Status: TERMINATED ·Phase: PHASE4
-
A Phase Ib/II in Patients With Acute Ischemic Stroke
NCT02963376 ·Status: COMPLETED ·Phase: PHASE1
-
APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study
NCT02640222 ·Status: COMPLETED
-
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
NCT03766581 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Thrombolysis and NOAC
NCT06749834 ·Status: RECRUITING ·Phase: PHASE3
-
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731 ·Status: UNKNOWN ·Phase: NA
-
Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
NCT02042534 ·Status: COMPLETED ·Phase: PHASE2
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314 ·Status: RECRUITING ·Phase: NA
-
Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
NCT00931788 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
NCT02501434 ·Status: SUSPENDED ·Phase: PHASE2
-
Study of the Follow-up of Stroke Treated With Anticoagulants
NCT03292575 ·Status: COMPLETED
-
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
NCT00494871 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Argatroban Plus R-tPA for Acute Ischemic Stroke
NCT03740958 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
NCT05415150 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
NCT00046761 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety Study of PP-007 in Subjects With Acute Ischemic Stroke
NCT04677777 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NCT06058130 ·Status: RECRUITING ·Phase: NA
-
Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke)
NCT02607358 ·Status: COMPLETED